{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0008569/OMIM:188570","label":"Thyroid hormone resistance, generalized, autosomal dominant","mondoId":"MONDO:0008569","onsetQualifier":null,"recordKeys":["0de8565729f1f6a3b4c867338dcd33be582a3e8063b9c0c0d948f3309922d7f1","408f81870aaeb04ca4c3a30d32e1b95d1539f2825db1cdfa7a63408bfa31ace2","43cac873818cac10fadd26bcd0fabb0e2a605b1736247ba85e689571b432afa4","908ad318b2a07f2ffb6147957a9b8a23f1996d01b8488556b15895d110accb6c","c3afd826130af8f1d25994dfbdd949036bb60facfa572b0df54e50106afca442","d33890ef0ed4b43edcf2733332f3a80f6fb25a6e96c607dc0f055853410f69a9","f55320a13fcbb1c99a616b7334bc0573d1dd4905e7dac3e48f546488f7243ac9"],"recordQualifiers":{},"scopeLabel":"OMIM:188570","sourceIds":["OMIM:188570"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0008569/OMIM:188570"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":7,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"omim":1,"orphanet":0,"published":6}},"features":[{"hpoId":"HP:0007018","label":"Attention deficit hyperactivity disorder","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language","primary":false},{"hpoId":"HP:0025484","label":"Elevated circulating thyroglobulin concentration","primary":false},{"hpoId":"HP:0000853","label":"Goiter","primary":false},{"hpoId":"HP:0002930","label":"Impaired sensitivity to thyroid hormone","primary":false},{"hpoId":"HP:0011788","label":"Increased circulating free T3","primary":false},{"hpoId":"HP:0033077","label":"Increased circulating free T4 concentration","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0008569","records":[{"frequencyKind":"count","key":"0de8565729f1f6a3b4c867338dcd33be582a3e8063b9c0c0d948f3309922d7f1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0025484","is_excluded":false,"label":"Elevated circulating thyroglobulin concentration","onset_id":null,"reference":"PMID:2510172","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"408f81870aaeb04ca4c3a30d32e1b95d1539f2825db1cdfa7a63408bfa31ace2","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0033077","is_excluded":false,"label":"Increased circulating free T4 concentration","onset_id":null,"reference":"PMID:2510172","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"43cac873818cac10fadd26bcd0fabb0e2a605b1736247ba85e689571b432afa4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0007018","is_excluded":false,"label":"Attention deficit hyperactivity disorder","onset_id":null,"reference":"PMID:2510172","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"908ad318b2a07f2ffb6147957a9b8a23f1996d01b8488556b15895d110accb6c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"TAS","frequency_raw":"2/2","hpo_id":"HP:0011788","is_excluded":false,"label":"Increased circulating free T3","onset_id":null,"reference":"OMIM:188570","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"c3afd826130af8f1d25994dfbdd949036bb60facfa572b0df54e50106afca442","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000853","is_excluded":false,"label":"Goiter","onset_id":null,"reference":"PMID:2510172","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d33890ef0ed4b43edcf2733332f3a80f6fb25a6e96c607dc0f055853410f69a9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:2510172","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f55320a13fcbb1c99a616b7334bc0573d1dd4905e7dac3e48f546488f7243ac9","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:188570","disease_name":"Thyroid hormone resistance, generalized, autosomal dominant","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002930","is_excluded":false,"label":"Impaired sensitivity to thyroid hormone","onset_id":null,"reference":"PMID:2510172","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"thyroid-hormone-resistance-generalized-autosomal-dominant","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"thyroid hormone resistance, generalized, autosomal dominant"},"schemaVersion":1}